SLDB — Solid Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Solid Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	155	208	214	124	149
Net Total Accounts Receivable
Net Total Receivables	—	0.11	0	—	—
Prepaid Expenses
Total Current Assets	159	223	220	130	157
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11.7	7.6	38.6	33.2	29
Other Long Term Assets
Total Assets	171	232	260	165	189
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	24.5	23.6	22.5	14.5	30.3
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	39.1	24.2	48.6	38.5	51.4
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	132	208	212	126	137
Total Liabilities & Shareholders' Equity	171	232	260	165	189
Total Common Shares Outstanding